全文获取类型
收费全文 | 4624篇 |
免费 | 307篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 93篇 |
儿科学 | 111篇 |
妇产科学 | 40篇 |
基础医学 | 681篇 |
口腔科学 | 50篇 |
临床医学 | 454篇 |
内科学 | 680篇 |
皮肤病学 | 89篇 |
神经病学 | 807篇 |
特种医学 | 120篇 |
外科学 | 752篇 |
综合类 | 42篇 |
一般理论 | 2篇 |
预防医学 | 312篇 |
眼科学 | 193篇 |
药学 | 235篇 |
中国医学 | 5篇 |
肿瘤学 | 272篇 |
出版年
2023年 | 20篇 |
2022年 | 25篇 |
2021年 | 74篇 |
2020年 | 43篇 |
2019年 | 63篇 |
2018年 | 89篇 |
2017年 | 64篇 |
2016年 | 90篇 |
2015年 | 108篇 |
2014年 | 121篇 |
2013年 | 147篇 |
2012年 | 268篇 |
2011年 | 252篇 |
2010年 | 150篇 |
2009年 | 115篇 |
2008年 | 263篇 |
2007年 | 261篇 |
2006年 | 261篇 |
2005年 | 244篇 |
2004年 | 227篇 |
2003年 | 233篇 |
2002年 | 219篇 |
2001年 | 122篇 |
2000年 | 137篇 |
1999年 | 117篇 |
1998年 | 68篇 |
1997年 | 54篇 |
1996年 | 41篇 |
1995年 | 35篇 |
1994年 | 38篇 |
1993年 | 32篇 |
1992年 | 54篇 |
1991年 | 58篇 |
1990年 | 43篇 |
1989年 | 51篇 |
1988年 | 60篇 |
1987年 | 48篇 |
1986年 | 51篇 |
1985年 | 53篇 |
1984年 | 27篇 |
1983年 | 33篇 |
1982年 | 21篇 |
1981年 | 23篇 |
1979年 | 21篇 |
1978年 | 20篇 |
1977年 | 24篇 |
1971年 | 17篇 |
1970年 | 19篇 |
1967年 | 17篇 |
1913年 | 25篇 |
排序方式: 共有4938条查询结果,搜索用时 15 毫秒
101.
Hatem O. Abdallah Cindy Zhao Elinore Kaufman Justin Hatchimonji Robert A. Swendiman Lewis J. Kaplan Mark Seamon C. William Schwab Jose L. Pascual 《Journal of the American College of Surgeons》2021,232(2):159-168.e3
- Download : Download high-res image (270KB)
- Download : Download full-size image
102.
103.
104.
Edna Grünblatt Jasmin Bartl Zoya Marinova Susanne Walitza 《Journal of neural transmission (Vienna, Austria : 1996)》2013,120(1):131-139
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric disorders in children and adolescents, with up to 5 % affected worldwide. Twin and family studies on ADHD show its high familiality with heritability estimated around 70 %, but, to date, no specific polymorphism or gene was found to be specifically affected. Psychostimulants (amphetamine, methylphenidate) and non-psychostimulants (atomoxetine) are used successfully in ADHD therapy, but many of their mechanisms of action and their adverse effects are not yet fully understood. Therefore, both genetic findings and therapeutic interventions should be further investigated. One easy platform for such studies is in vitro analyses, which encompass neuronal cell culture studies, transfections of genetic constructs, binding and electrophysiology analyses. In this review, different methods will be referred in particular to ADHD findings, and new techniques will be mentioned for future studies of drug or genetic effects in vitro. 相似文献
105.
Insulin resistance is a major disorder that links obesity to type 2 diabetes mellitus (T2D). It involves defects in the insulin actions owing to a reduced ability of insulin to trigger key signaling pathways in major metabolic tissues. The pathogenesis of insulin resistance involves several inhibitory molecules that interfere with the tyrosine phosphorylation of the insulin receptor and its downstream effectors. Among those, growing interest has been developed toward the protein tyrosine phosphatases (PTPs), a large family of enzymes that can inactivate crucial signaling effectors in the insulin signaling cascade by dephosphorylating their tyrosine residues. Herein we briefly review the role of several PTPs that have been shown to be implicated in the regulation of insulin action, and then focus on the Src homology 2 (SH2) domain-containing SHP1 and SHP2 enzymes, since recent reports have indicated major roles for these PTPs in the control of insulin action and glucose metabolism. Finally, the therapeutic potential of targeting PTPs for combating insulin resistance and alleviating T2D will be discussed. 相似文献
106.
107.
Wolfgang Schoels MD David Steinhaus MD W. Ben Johnson MD Gilles OHara MD Joerg O. Schwab MD Inge Jenniskens MSc Paul J. DeGroot MS Feng Tang PhD Erhard Helmling MD EnTrust Clinical Study Investigators 《Heart rhythm》2007,4(7):879-885
BACKGROUND: Previous studies in implantable cardioverter-defibrillator (ICD) patients demonstrated the efficacy and safety of antitachycardia pacing (ATP) for rapid ventricular tachycardias (VT). To prevent shock delay in case of ATP failure, a new feature (ATP during charging) was developed to deliver ATP for rapid VT while charging for shock. OBJECTIVE: The purpose of this study was to determine the efficacy and safety of this new feature. METHODS: In a prospective, nonrandomized trial, patients with standard ICD indication received an EnTrust ICD. VT and ventricular fibrillation (VF) episodes were reviewed for appropriate detection, ATP success, rhythm acceleration, and related symptoms. RESULTS: In 421 implanted patients, 116 VF episodes occurred in 37 patients. Eighty-four (72%) episodes received ATP during or before charging. ATP prevented a shock in 58 (69%) of 84 episodes in 15 patients. ATP stopped significantly more monomorphic (77%) than polymorphic VTs (44%, P = .05). Five (6%) episodes accelerated after ATP but were terminated by the backup shock(s). No symptoms were related to ATP during charging. In four patients, 38 charges were saved by delivering ATP before charging. Of 98 induced VF episodes, 28% were successfully terminated by ATP versus 69% for spontaneous episodes (P <.01). CONCLUSION: Most VTs detected in the VF zone can be painlessly terminated by ATP delivered during charging, with a low risk of acceleration or symptoms. ATP before charging allows delivery of two ATP attempts before shock in the same time that would otherwise be required to deliver only one ATP plus a shock. It also offers potential battery energy savings. 相似文献
108.
109.
Stanulla M Schäffeler E Arens S Rathmann A Schrauder A Welte K Eichelbaum M Zanger UM Schrappe M Schwab M 《International journal of hematology》2005,81(1):39-44
The probability of event-free survival of childhood acute lymphoblastic leukemia (ALL) approaches 80% or more with the use of modern multiagent chemotherapeutic regimens. One major contribution to this success has been reduction of the rate of central nervous system (CNS) relapses to less than 5%. However, heterogeneity is observed with regard to the incidence of CNS relapse in homogenously treated patient populations. One potential explanation for this heterogeneity is variation in the genetic background of these populations. Glutathione S-transferase P1 and P-glycoprotein are implicated in resistance to a variety of chemotherapeutic agents and have been localized to the blood-brain barrier. In a matched case-control study, we investigated the associations between CNS relapse in childhood ALL and the presence of phenotypically relevant single nucleotide polymorphisms within the GSTP1 (codon 105 and 114) and MDR1 genes (ABCB1; coding for Pgp; exon 26, C3435T). Significant reductions in risk of CNS relapse were observed for patients homozygous for the GSTP1 Val105 allele as well as for patients with the MDR1 3435T/T or C/T genotype. For both genotypes, the effect was restricted to patients at intermediate or high risk of treatment failure. These results suggested a modulating role for host genetic variation in the development of CNS relapse in childhood ALL treated according to Berlin-Frankfurt-Münster protocols. 相似文献
110.